AzTrials
AzTrials

Shock WaveRCTNCT07750080

The Effect of Multimodal Approach of Electrotherapy Versus Shock Wave Therapy in Menopausal Women With Tennis Elbow.

A study testing multimodal electrotherapy, shock wave therapy and exercise in people with Shock Wave, run by October 6 University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Tennis Elbow (or Lateral Epicondylalgia) is one of the most common overload injuries that it is the most frequent cause of lateral elbow pain, occurring to people between 40-60 years of age. Read more about this study

Who is it for?
Ages 45 to 55 years, women only
Conditions the study is for
Shock Wave
What is being tested?
multimodal electrotherapy, shock wave therapy and exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteEgypt
Study dates
3 Mar 2026to 1 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 55 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • 1) forty five menopausel females suffer from chronic lateral epicondylitis from Department of out patient orthopedic clinic of 6 october hospital .
  • Their age ranged from 45 _55 years old 3) Their BMI will be 18.5 to 24.9 kg/m2. 4) Point tenderness at the lateral epicondyle. 5) Positive Cozen test 6) Symptoms duration of minimum 3 months

Who cannot join

  • Patients with cervical radiculopathy ,thoracic outlet syndrome ,
  • dysfunction in shoulder or elbow with corticosteroid injection in previous three months.
  • Their BMI more than 25 kg/m2.
  • Unrelated to any traumatic conditions
  • Any previous fracture elbow, wrist or hand
  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Heba ahmed, doctoral contact

01117671712

Heba.Ahmed.PT@o6u.edu.eg

Menna Mohmed, doctoral contact

01118758578

Mennamohmed.PT@o6u.edu.eg

Egypt1 site, 1 recruiting
  • Heba

    Cairo

    Heba ahmed, doctoral, 01117671712, Heba.Ahmed.PT@o6u.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: The Effect of Multimodal Approach of Electrotherapy Versus Extracorporeal Shock Wave Therapy in Menopausal Women With Tennis Elbow : A Randomized Controlled Trial.

Tennis Elbow (or Lateral Epicondylalgia) is one of the most common overload injuries that it is the most frequent cause of lateral elbow pain, occurring to people between 40-60 years of age. It is characterized by pain on the outside of the elbow, usually near the lateral epicondyle bone where the extensor carpi Brevis tendon attaches, aggravated by gripping or wringing activities During menopause period, declining estrogen levels can negatively impact tendon health. Estrogen plays a protective role in tendons, contributing to their strength and ability to withstand load.

Read the detailed description

As estrogen decreases, tendons may become weaker, less resilient, and more susceptible to injury, potentially leading to conditions like tendinopathy. This can often add to these feelings of pain and limit of function ; and possibly limit your movements in day to day activities. Multimodal electrotherapy ( low level laser therapy plus interferential current) and extracorporeal shock wave therapy can be used to improve this problem.

Conditions
Shock Wave
Being tested
multimodal electrotherapy, shock wave therapy, exercise
Keywords
tennis elbow
Medical subject headings
Tennis Elbow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • multimodal electrotherapyOther

    subjects will receive multimodal approach of electrotherapy (LLLT , and IFC) with conventional physical therapy modalities in the form of (stretch and strengthen exercises ) 3 sessions every week for 6 weeks

  • shock wave therapyOther

    subjects will receive shock wave therapy with conventional physical therapy modalities 3 sessions every week for 6 weeks.

  • exerciseOther

    subjects will receive with conventional physical therapy modalities only in the form of (stretching and strengthening therapeutic exercises ) 3 sessions every week for 6 weeks.

Study groups in NCT07750080
Study groupRoleWhat they receive
Group AExperimentalIt consisted of fifteen menopause women receive the multimodal electrotherapy ( low level laser therapy and interferential current ) with conventional physical therapy as form of stretching and strengthen exercise
Receives: Other: multimodal electrotherapy
Group BExperimentalIt consisted of fifteen menopause women receive receives extracorporeal shock wave therapy with conventional physical therapy
Receives: Other: shock wave therapy
Group CExperimentalIt consisted of fifteen menopause women receive conventional physical therapy
Receives: Other: exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analogue scale

    The VAS consists of a 10-cm line, with the left extremity indicating ''no pain'' and the right extremity indicating ''unbearable pain.'' Participants asked to use the scale to indicate their current level of pain Higher values suggest more intense pain ,It was found that VAS provide valid and reliable assessments for the affective magnitude, as well as the sensation intensity of pain.

    Measured: 6 weeks

  2. hand grip

    Grip hand strength will be assessed by hand held dynamometer

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2026
  2. Study start3 Mar 2026
  3. Primary completion3 Aug 2026 (estimated)
  4. Study completion1 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07750080
Sponsor's protocol ID
000115
Acronym
RCT
Status last verified
Aug 2026
First submitted
30 Jul 2026
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing multimodal electrotherapy, shock wave therapy and exercise in people with Shock Wave, run by October 6 University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Heba ahmed, doctoral (01117671712, Heba.Ahmed.PT@o6u.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analogue scale (time frame: 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in